HIV prevalence in the Democractic Republic of Congo (DRC) is estimated to be 1.2%, yet access to HIV testing (50%) and ART coverage (38%) are also among the lowest in West and Central Africa region (PNLS 2016 figures). Consequently, MSF staff treat many patients with advanced HIV or AIDS at MSF’s Centre hospitalier de Kabinda (CHK), where MSF provides the only free, high quality specialised hospital care for advanced HIV in Kinshasa. Due to a host of structural and community barriers, people living with HIV only seek care when they are very ill, and mortality rates remain very high.
This report presents MSF’s clinical experience and epidemiological data from treating advanced HIV at CHK and other supported health facilities, along with recommendations for minimum diagnostic and therapeutic packages for advanced HIV at primary, referral and hospital levels, and costings for hospitalisation. The report calls for the funding and implementation of a referral system and free outpatient care and hospitalisation for advanced HIV in Kinshasa. The report also draws on the available literature and includes testimonies from patients who received hospital care in MSF’s Kinshasa HIV project and healthcare professionals specialized in the treatment of advanced HIV.
This report comprises a joint contribution by our multi-disciplinary team and is intended for use by authorities in public hospitals, health care professionals, medical decision makers in the DRC’s Ministry of Health and its partners, political decision makers and the country’s major donors (the Global Fund, PEPFAR and USAID).
This report is available in French and in English